Skip to main content
OpenTrials
Completed

NCT Number: NCT01091090

Cognitive Behavioral Smoking Cessation Intervention for Adults With Chronic Pain

Millions of individuals with chronic pain smoke and our preliminary research suggests that currently available strategies to help people quit smoking may not be effective for individuals with chronic pain. This is important in that smokers with chronic pain have worse pain-related health outcomes compared to nonsmokers with chronic pain. The primary aim of this research project is to develop a smoking cessation intervention for specific use in an outpatient clinical setting for smokers with chronic pain.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Smoking Cessation Behavior Chemically-Induced Disorders Chronic Pain Health Behavior Mental Disorders Neurologic Manifestations Pain Pathological Conditions, Signs and Symptoms Signs and Symptoms Substance-Related Disorders Tobacco Use Disorder

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Mayo Pain Rehabilitation Center

Rochester, Minnesota, 55905, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Chronic pain
  • Age > 18 years
  • Cigarette smoker > 10 per day

Exclusion criteria

  • Concurrent substance use disorder other than nicotine dependence
  • Concurrent major psychiatric disorder

Treatment and study plan

Cognitive behavioral

Behavioral

Cognitive behavioral intervention for smoking cessation

Other names: Cognitive, Behavioral, Smoking Cessation

Control

Behavioral

Treatment as usual

Primary outcomes

  1. The key measurement to be used to assess the effect of the experimental intervention will be the status of cigarette smoking at 6-month follow-up.

    Time frame: 6 months

    The smoking status will be determined by assessing the 7-day point prevalence use of cigarettes which is defined as the use of any cigarettes within the preceding 7 days of the follow-up date at 6-months.

Secondary outcomes

  1. A key secondary outcome measure will be self-report pain severity at 6-months following completion of the experimental intervention.

    Time frame: 6 month

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Registry information

Important dates

Study start
2009
Primary completion
2011
Study completion
2011
First posted
Mar 23, 2010
Registry last updated
May 25, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.